These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 16825348

  • 21. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A, Dalla Costa LM, Nogueira KS, Matos AP, Gales AC, Paganini MC, Castro ME, Raboni SM.
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [Abstract] [Full Text] [Related]

  • 22. Characterisation of the first VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia.
    Lepsanovic Z, Libisch B, Tomanovic B, Nonkovici Z, Balogh B, Füzi M.
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):447-54. PubMed ID: 19130752
    [Abstract] [Full Text] [Related]

  • 23. Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene.
    Siarkou VI, Vitti D, Protonotariou E, Ikonomidis A, Sofianou D.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1325-30. PubMed ID: 19164147
    [Abstract] [Full Text] [Related]

  • 24. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ.
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [Abstract] [Full Text] [Related]

  • 25. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N, Zhang J, Kaufmann ME, Yarde S, Tomas Mdel M, Faris C, Vardhan MS, Dawson S, Cotterill SL, Livermore DM.
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [Abstract] [Full Text] [Related]

  • 26. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan.
    Mano Y, Saga T, Ishii Y, Yoshizumi A, Bonomo RA, Yamaguchi K, Tateda K.
    BMC Microbiol; 2015 Feb 21; 15():41. PubMed ID: 25881168
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT.
    Diagn Microbiol Infect Dis; 2007 Oct 21; 59(2):211-6. PubMed ID: 17521840
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
    Van der Bij AK, Van Mansfeld R, Peirano G, Goessens WH, Severin JA, Pitout JD, Willems R, Van Westreenen M.
    Int J Antimicrob Agents; 2011 Jun 21; 37(6):513-8. PubMed ID: 21497065
    [Abstract] [Full Text] [Related]

  • 34. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
    Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R.
    Clin Infect Dis; 2000 Nov 21; 31(5):1119-25. PubMed ID: 11073738
    [Abstract] [Full Text] [Related]

  • 35. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, Velez JD, Castañeda CR, Recalde M, Livermore DM.
    J Clin Microbiol; 2004 Nov 21; 42(11):5094-101. PubMed ID: 15528701
    [Abstract] [Full Text] [Related]

  • 36. Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia.
    Khosravi Y, Tay ST, Vadivelu J.
    J Med Microbiol; 2011 Jul 21; 60(Pt 7):988-994. PubMed ID: 21436370
    [Abstract] [Full Text] [Related]

  • 37. Metallo-β-lactamase expression confers an advantage to Pseudomonas aeruginosa isolates compared with other β-lactam resistance mechanisms, favoring the prevalence of metallo-β-lactamase producers in a clinical environment.
    Corich L, Dolzani L, Tonin EA, Vitali LA, Lagatolla C.
    Microb Drug Resist; 2010 Sep 21; 16(3):223-30. PubMed ID: 20735174
    [Abstract] [Full Text] [Related]

  • 38. Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.
    Toleman MA, Biedenbach D, Bennett DM, Jones RN, Walsh TR.
    J Antimicrob Chemother; 2005 Jan 21; 55(1):61-70. PubMed ID: 15574470
    [Abstract] [Full Text] [Related]

  • 39. Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.
    Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier JD, Nucleo E, Spalla M, Li Bergoli M, Rossolini GM.
    J Clin Microbiol; 2005 Aug 21; 43(8):3824-8. PubMed ID: 16081918
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.